BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 12816345)

  • 21. Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.
    Chen L; Adar R; Yang X; Monsonego EO; Li C; Hauschka PV; Yayon A; Deng CX
    J Clin Invest; 1999 Dec; 104(11):1517-25. PubMed ID: 10587515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
    Colvin JS; Bohne BA; Harding GW; McEwen DG; Ornitz DM
    Nat Genet; 1996 Apr; 12(4):390-7. PubMed ID: 8630492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mutations of the fibroblast growth factor receptor 3 gene in achondroplasia].
    Zhao P; Ma H; Wang Y; Mi Z; Wu Y; Jiang M; Gao H; Li Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):16-8. PubMed ID: 9949234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achondroplasia in Sweden caused by the G1138A mutation in FGFR3.
    Alderborn A; Anvret M; Gustavson KH; Hagenäs L; Wadelius C
    Acta Paediatr; 1996 Dec; 85(12):1506-7. PubMed ID: 9001669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Updated treatment of achondroplasia].
    Seino Y
    Clin Calcium; 2009 Mar; 19(3):432-6. PubMed ID: 19252254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid detection of FGFR3 gene mutation in achondroplasia by DHPLC system-coupling heteroduplex and fluorescence-enhanced primer-extension analysis.
    Su YN; Lee CN; Chien SC; Hung CC; Chien YH; Chen CA
    J Hum Genet; 2004; 49(8):399-403. PubMed ID: 15221641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis for the treatment of achondroplasia.
    Yamanaka Y; Ueda K; Seino Y; Tanaka H
    Horm Res; 2003; 60 Suppl 3():60-4. PubMed ID: 14671399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
    Wang Q; Green RP; Zhao G; Ornitz DM
    Development; 2001 Oct; 128(19):3867-76. PubMed ID: 11585811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
    Adar R; Monsonego-Ornan E; David P; Yayon A
    J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achondroplasia: Development, pathogenesis, and therapy.
    Ornitz DM; Legeai-Mallet L
    Dev Dyn; 2017 Apr; 246(4):291-309. PubMed ID: 27987249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fibroblast growth factor receptor and achondroplasia].
    Tanaka H
    Clin Calcium; 2006 Nov; 16(11):1888-93. PubMed ID: 17079857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
    Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
    Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
    Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
    Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts.
    Nguyen HB; Estacion M; Gargus JJ
    Hum Mol Genet; 1997 May; 6(5):681-8. PubMed ID: 9158142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gly374Arg mutation in Fgfr3 causes achondroplasia in mice].
    Wang JM; Du XL; Li CL; Yin LJ; Chen B; Sun J; Su N; Zhao L; Song RH; Song WW; Chen L; Deng CX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):537-41. PubMed ID: 15583977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.
    Garcia S; Dirat B; Tognacci T; Rochet N; Mouska X; Bonnafous S; Patouraux S; Tran A; Gual P; Le Marchand-Brustel Y; Gennero I; Gouze E
    Sci Transl Med; 2013 Sep; 5(203):203ra124. PubMed ID: 24048522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dwarfism in Dexter cattle is not caused by the mutations in FGFR3 responsible for achondroplasia in humans.
    Usha AP; Lester DH; Williams JL
    Anim Genet; 1997 Feb; 28(1):55-7. PubMed ID: 9124710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse models orthologous to FGFR3-related skeletal dysplasias.
    Brodie SG; Deng CX
    Pediatr Pathol Mol Med; 2003; 22(1):87-103. PubMed ID: 12687892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chinese achondroplasia is also defined by recurrent G380R mutations of the fibroblast growth factor receptor-3 gene.
    Niu DM; Hsiao KJ; Wang NH; Chin LS; Chen CH
    Hum Genet; 1996 Jul; 98(1):65-7. PubMed ID: 8682509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
    Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
    Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.